Choquette, D., Bessette, L., Alemao, E., Haraoui, B., Massicotte, F., Mtibaa, M., Muratti, E., Pelletier, J., Postema, R., Raynauld, J., Rémillard, M., Sauvageau, D., Turcotte, A., Villeneuve, Έ., & Coupal, L. (n.d.). aB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry. Annals of the rheumatic diseases, 76, 1188. http://access.bl.uk/ark:/81055/vdc_100135134314.0x000061